Search Within

Melanoma Disease Management Team

Formats
  1. Journal Article (1607)
  2. Meeting Abstract (791)
  3. Book Section (104)
  4. Review (72)
  5. Editorial (58)
  6. Research Letter (45)
  7. Guidelines (26)
  8. Correspondence (23)
  9. Conference Paper (22)
  10. Miscellaneous (16)
  11. Book Whole (11)
Groups
  1. Department of Medicine (1693)
  2. Survivorship Research (1195)
  3. Solid Tumor Oncology Division (1054)
  4. Department of Pathology and Laboratory Medicine (958)
  5. Surgery (948)
  6. Melanoma and Immunotherapeutics Service (793)

More Groups

People
  1. Klaus Busam (699)
  2. Daniel Coit (543)
  3. Allan Halpern (401)
  4. Michael Postow (369)
  5. Alexander Shoushtari (247)
  6. Jedd Wolchok (222)

More People

Years
  1. 2025 (94)
  2. 2024 (138)
  3. 2023 (160)
  4. 2022 (167)
  5. 2021 (149)
  6. 2020 (142)

More Years

Publications
  1. Journal of Clinical Oncology (269)
  2. Annals of Surgical Oncology (221)
  3. Journal of the American Academy of Dermatology (123)
  4. Journal of Investigative Dermatology (84)
  5. Modern Pathology (67)
  6. Journal for ImmunoTherapy of Cancer (65)

More Publications

Publishers
  1. Springer (343)
  2. American Society of Clinical Oncology (285)
  3. Elsevier Inc. (231)
  4. Lippincott Williams & Wilkins (229)
  5. Wiley Blackwell (162)
  6. Elsevier Science, Inc. (160)

More Publishers

Results (2775)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Specificity analysis of sera from breast and prostate cancer patients vaccinated with MUC1-KLH and MUC2-KLH conjugate vaccines
    Meeting Abstract

    Ragupathi, G.; Adluri, R.; Amaravathi, R.; Howard, L.; Gilewski, T.; Slovin, S. F.; Scher, H. I.; Norton, L.; Livingston, P. O.
    Proceedings of the American Association for Cancer Research Annual Meeting (1999)

    Fulltext@MSK | Save
  • MUC-2-KLH conjugate vaccine: Immunogenicity in patients with relapsed prostate cancer
    Meeting Abstract

    Slovin, S. F.; Ragupathi, G.; Donaldson, C.; Olkiewicz, K.; Terry, K.; DePaolo, R.; Bauso, A.; Livingston, P. O.; Scher, H. I.
    Proceedings of the American Association for Cancer Research Annual Meeting (1999)

    Fulltext@MSK | Save
  • MAGE-3 in malignant melanoma: Frequency of expression and correlation with prognostic parameters
    Meeting Abstract

    Busam, K. J.; Iversen, K.; Coplan, K. A.; Old, L. J.; Berwick, M.; Jungbluth, A. A.
    Modern Pathology (1999)

    Fulltext@MSK | Save
  • Epidermal growth factor, estrogen and progesterone receptor expression in primary sweat gland carcinomas and primary and metastatic mammary carcinomas
    Meeting Abstract

    Busam, K. J.; Tan, L. K.; Granter, S. R.; Kohler, S.; Junkins-Hokpins, J.; Rosen, P. P.
    Modern Pathology (1999)

    Fulltext@MSK | Save
  • Detection of metastases in sentinel lymph nodes (SLN) of malignant melanoma (MM) patients using morphology, immunohistochemistry (IHC) and reverse transcriptase polymerase chain reaction (RT PCR)
    Meeting Abstract

    Busam, K. J.; Coit, D.; Bieligk, S.; Bhattacharya, S.; Ghossein, R.
    Modern Pathology (1999)

    Fulltext@MSK | Save
  • Tumor-associated antigen MAGE-3 - Analysis of antigen expression in normal tissue and malignant neoplasms
    Meeting Abstract

    Jungbluth, A. A.; Spagnoli, G. C.; Kolb, D.; Coplan, K.; Iversen, K.; Chen, Y. T.; Busam, K. J.; Old, L. J.
    Laboratory Investigation (1999)

    Fulltext@MSK | Save
  • MAGE-3 in malignant melanoma: Frequency of expression and correlation with prognostic parameters
    Meeting Abstract

    Busam, K. J.; Iversen, K.; Coplan, K. A.; Old, L. J.; Berwick, M.; Jungbluth, A. A.
    Laboratory Investigation (1999)

    Fulltext@MSK | Save
  • Epidermal growth factor, estrogen and progesterone receptor expression in primary sweat gland carcinomas and primary and metastatic mammary carcinomas
    Meeting Abstract

    Busam, K. J.; Tan, L. K.; Granter, S. R.; Kohler, S.; Junkins-Hopkins, J.; Rosen, P. P.
    Laboratory Investigation (1999)

    Fulltext@MSK | Save
  • Detection of metastases in sentinel lymph nodes (SLN) of malignant melanoma (MM) patients using morphology. Immunohistochemistry (IHC) and reverse transcriptase polymerase chain reaction (RT PCR)
    Meeting Abstract

    Busam, K. J.; Coit, D.; Bieligk, S.; Bhattacharya, S.; Ghossein, R.
    Laboratory Investigation (1999)

    Fulltext@MSK | Save
  • Anti-tyrosinase monoclonal antibody T311 - Immunohistochemical reactivity pattern in metastatic malignant melanoma and non-melanocytic neoplasms
    Meeting Abstract

    Jungbluth, A. A.; Chen, Y. T.; Stockert, E.; Iversen, K.; Kolb, D.; Coplan, K.; Old, L. J.; Busam, K. J.
    Laboratory Investigation (1999)

    Fulltext@MSK | Save